Skip to content

Electrical Impedance Tomography-Based Prognostic Model for ARDS

Electrical Impedance Tomography-Based Prognostic Model for ARDS: A Multicenter, Prospective, Observational Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06967207
Enrollment
625
Registered
2025-05-13
Start date
2025-04-15
Completion date
2027-12-31
Last updated
2025-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Distress Syndrome (ARDS), Ventilator-induced Lung Injury

Brief summary

This multicenter, prospective, observational study aims to develop and validate an EIT-based prognostic model for ARDS. By focusing on the pathophysiological characteristics of ARDS and the causes of ventilator-induced lung injury, the investigators intend to establish a prognostic model that reveals lung injury and heterogeneity, enabling risk stratification and guiding individualized treatment.

Interventions

OTHERNot applicable- observational study

Not applicable- observational study

Sponsors

XiaoJing Zou,MD
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Meet the new 2023 ARDS global definition; 2. Age 18-80 years

Exclusion criteria

1. Expected death within 24 hours of screening; 2. Metastatic cancer (active malignancy with distant metastases); 3. Severe psychiatric disorders; 4. Pregnancy or postpartum status; 5. Pneumothorax or moderate to large pleural effusion without adequate drainage; 6. Chronic respiratory failure; 7. Patients with pulmonary embolism or pulmonary hypertension; 8. Heart failure patients: EF \<50% or NYHA class III or IV; 9. Patient/family refusal to participate; 10. Participation in another interventional trial within 3 months prior to enrollment

Design outcomes

Primary

MeasureTime frame
28-day mortality rateFrom date of study enrollment (Day 0) until Day 28

Secondary

MeasureTime frame
60-day all-cause mortality rate60 days post-enrollment
90-day all-cause mortality rate90 days post-enrollment
Duration of mechanical ventilation (days)From intubation to successful extubation, up to 28 days
ICU mortality rateFrom ICU admission to discharge, up to 24 weeks
ICU length of stay (days)From ICU admission to discharge, up to 24 weeks
Hospital length of stayFrom hospital admission to discharge, up to 24 weeks
Ventilator-free days (VFDs) at 28 days28 days post-enrollment

Countries

China

Contacts

Primary ContactXiaojing Zou Zou
249126734@qq.com84+13995518630

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026